Gemma Taylor discusses new research on the effects of smoking cessation treatment options for people with past or current major depressive disorder.
[read the full story...]
Emiliana Tonini looks at how sleep is recorded and treated in people with serious mental illness—and how it affects their engagement with services. The study finds that sleep is rarely part of routine clinical assessment, and recommended sleep treatments are hardly ever used.
[read the full story...]
Lisa Lloyd and Milagros Pallavicini review a recent study on psychotherapies for 8 mental disorders, finding that while most outperform control treatments, response rates remain modest.
[read the full story...]
This Swedish cohort study, blogged by Duncan Swiffen, is yet more evidence for lithium as an excellent treatment for people with bipolar disorder. This time it comes out on top in terms of preventing depression-related hospitalisation.
[read the full story...]
Jakob Yianni celebrates National Walking Day by summarising a recent review which finds that a wide variety of activities can help treat depression, ranging from yoga and tai chi to high-intensity strength and aerobic training.
[read the full story...]
Jenna Jacob summarises a co-produced systematic review and meta-analysis exploring rumination and worry as transdiagnostic targets for mental health interventions in young people.
[read the full story...]
Olga Lainidi summarises a recently Dutch RCT which asks: is behavioural activation a more cost-effective and accessible alternative to primary care treatments for older adults with depression?
[read the full story...]
In her debut blog (and the Mental Elf’s first body-focused repetitive behaviours blog), Mallory Moore summarises a systematic review investigating whether internalised stigma can predict depression.
[read the full story...]
Kirsten Lawson and Douglas Badenoch review the new randomised controlled trial by Cleare et al, published today in The Lancet Psychiatry, directly comparing the clinical and cost effectiveness of lithium and quetiapine as augmentation treatments for patients with ‘treatment resistant depression’.
[read the full story...]
Dr Rachel Reid-McCann discusses the latest research on dosage of levonorgestrel-releasing intrauterine system (LNG-IUS) and the risk of depression. A well conducted study from Denmark “provides evidence of a dose-dependent association between LNG exposure and risk of subsequent depression across three dosages”.
[read the full story...]
